Braskem S.A. BAK · NYSE
$1.81 -1.63% (-$0.03)
Summary
29 / 100 · Bulios Score
What speaks for it
None of the indicators we track stands out on the positive side.
What to watch
- The company made a loss over the last 12 months.
- Revenue fell by 10% a year over the last 3 years.
- Repaying its net debt would take 6.4 years of operating profit.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (BRL)
Diluted EPS (BRL)
- Analyst estimate
Revenue grew by 3.4% a year over 5 years. Over the last 3 years it fell by 10% a year.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of R$ 5.54B.
Profitability in detailIs it financially healthy?
Debt is a burdenOver the last 12 months it spent more cash than it brought in. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Neutral- Buy 1
- Hold 3
- Sell 2
Today's price within the analysts' price targets
The average target of $1.5 is 17% below today's price. 17% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Ethylene Propylene 32%
- Benzene Toluene And Xylene 28%
- Other 1 18%
- Butadiene 12%
- Cumene 6.6%
- Other 3.8%
By region
- Others 100%
Ethylene Propylene brings in 32% of revenue.
Segments in detail